Showing results (231-240 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
The prognostic role of blood lymphocyte subset distribution in patients with resected high-risk primary or regionally metastatic melanomaMicaela Hernberg, Petri S Mattila, Marjo Rissanen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
Role of chemotherapy with gemcitabine plus 5-fluorouracil and chemoimmunotherapy in metastatic renal cell cancer (mRCC)Sebastiano Buti, Matteo Brighenti, Cristiano Bongiovanni, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2008
Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapyYuriko Fujita, Ann M Leen, Jiali Sun, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2008
Minor role of bystander tolerance to fetal calf serum in a peptide-specific dendritic cell vaccine model against autoimmunity: comparison with serum-free culturesSusanne Röner, Elisabeth Zinser, Mauritius Menges, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Immunostimulatory effects of CpG-ODN upon dendritic cell-based immunotherapy in a murine melanoma modelShari Pilon-Thomas, Wenbin Li, Jon J Briggs, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 2, 2007
Dendritic cell-based full-length survivin vaccine in treatment of experimental tumorsSrinivas Nagaraj, Vladimir Pisarev, Leo Kinarsky, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 2, 2007
Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patientsAdriaan Bins, Henk Mallo, Johan Sein, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
IL-2 and IL-15 each mediate de novo induction of FOXP3 expression in human tumor antigen-specific CD8 T cellsMojgan Ahmadzadeh, Paul A Antony, Steven A RosenbergJournal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Monocytes immunoselected via the novel monocyte specific molecule, CD300e, differentiate into active migratory dendritic cellsGeorgina J Clark, Lubomira Jamriska, Min Rao, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptorsManfred Lehner, Patrick Morhart, Andrea Stilper, et al.Pageof 175